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Abstract 
Ethanol and its metabolite acetaldehyde have been classified as carcinogens for the upper 
aerodigestive tract, liver, breast and colorectum. Whereas mechanisms related to oxidative 
stress and Cyp2e1 induction seem to prevail in the liver and acetaldehyde has been 
proposed to play a crucial role in the upper aerodigestive tract, pathological mechanisms in 
the colorectum have not been clarified yet. Moreover, all evidence for a pro-carcinogenic 
role of ethanol in colorectal cancer is derived from correlations observed in epidemiological 
studies or from rodent studies with additional carcinogen application or tumour suppressor 
gene inactivation. In the current study, wildtype mice and mice with depletion of Aldehyde 
dehydrogenase 1b1 (Aldh1b1), an enzyme which has been proposed to play an important 
role in acetaldehyde detoxification in the intestines, received ethanol in drinking water for 
one year. Long-term ethanol consumption led to intestinal tumour development in wildtype 
and Aldh1b1-depleted mice, but no intestinal tumours were observed in water-treated 
controls. Moreover, a significant increase in DNA damage was detected in the large 
intestinal epithelium of ethanol-treated mice of both genotypes compared with the respective 
water-treated groups, along with increased proliferation of the small and large intestinal 
epithelium. Aldh1b1 depletion led to increased plasma acetaldehyde levels in ethanol-
treated mice, to a significant aggravation of ethanol-induced intestinal hyperproliferation, 
and to more advanced features of intestinal tumours, but it did not affect intestinal tumour 
incidence. These data indicate that ethanol consumption can initiate intestinal 
tumourigenesis without any additional carcinogen treatment or tumour suppressor gene 
inactivation, and we provide evidence for a role of Aldh1b1 in protection of the intestines 
from ethanol-induced damage, as well as for both carcinogenic and tumour-promoting 
functions of acetaldehyde, including increased progression of ethanol-induced tumours. 
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Introduction 
Alcohol is one of the most commonly used recreational drugs, which in 2002 was consumed 
by more than 1.9 billion adults worldwide, with 22% of men and 3% of women drinking 40 g 
ethanol or more per day [1]. Ethanol and its metabolite acetaldehyde have been classified 
as a group one carcinogens by the International Agency for Research on Cancer for the 
locations upper aerodigestive tract, liver, breast and colorectum [1]. 
We aim to further elucidate the role of ethanol in colorectal carcinogenesis. Evidence for a 
pro-carcinogenic function of ethanol in colorectal cancer (CRC) is mainly derived from 
epidemiological studies. A pooled meta-analysis of eight prospective cohort studies reported 
a multivariate relative risk of 1.41 for persons who consumed 45 g ethanol or more per day 
[2] (5.6 UK alcohol units), which is supported by two other meta-analyses of prospective 
cohort and case-control studies with similar results [3, 4]. Furthermore, CRC mutation 
analysis in the EPIC-Norfolk study revealed a significant association of high alcohol intake 
and p53 mutations in patients with advanced Dukes’ stage colorectal cancer [5] as well as 
a significant association of high alcohol intake and truncating mutations of adenomatosis 
polyposis coli (APC) [6]. 
Direct evidence for the genotoxicity of ethanol in the intestines along with mechanistic data 
from rodent models is scarce. Most data are derived from rodent studies where ethanol led 
to increased tumour formation when co-administered with a chemical carcinogen (reviewed 
in [1, 7]). Furthermore, two studies reported an increased polyp number and size after 
ethanol treatment of ApcMin mice, which are pre-disposed to intestinal tumour development 
due to a germline mutation in the Apc gene [8, 9]. However, there are presently no long-
term ethanol consumption studies demonstrating intestinal tumour induction in rodents by 
ethanol treatment alone.  
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There is a growing body of mechanistic hypotheses for genotoxic as well as co-carcinogenic 
effects of ethanol in the intestines derived from human, rodent and tissue culture studies, 
which are systematically reviewed elsewhere [7]. Hypotheses include adverse effects of 
acetaldehyde, generation of free radicals, cytochrome P450 induction, increased efficiency 
of carcinogens and hyperproliferation. However, the exact mechanisms remain unclear and 
findings have been inconsistent.  
This study focussed on the direct genotoxic effects of ethanol in vivo. DNA damage after 
ethanol consumption has been suggested to arise from reactive (oxygen and nitrogen) 
species, whose generation is mainly driven by cytochrome P450 2e1 (CYP2E1), as well as 
from DNA adducts of acetaldehyde [10, 11]. Ethanol is oxidised to highly reactive 
acetaldehyde by alcohol dehydrogenases (ADH) and also by CYP2E1 in the liver. Aldehyde 
dehydrogenases (ALDH) catalyse further oxidation of acetaldehyde to acetate. Systemic 
ethanol clearance occurs in the liver. The intestinal epithelium is exposed to acetaldehyde 
generated by mucosal ADHs and from the bloodstream as well as from the intestinal lumen, 
where acetaldehyde generation is linked to the intestinal microbiota [10-12]. Whereas 
oxidative stress is believed to be most important in the liver, there is also evidence for a role 
of CYP2E1 in intestinal oxidative stress after ethanol consumption [11, 13]. 
Strong evidence for a role for acetaldehyde in ethanol-related cancers comes from 
individuals with polymorphisms in ADH and ALDH enzymes that lead to increased 
acetaldehyde levels causing an increased cancer risk [12]. ALDH isoforms with highest 
affinity for acetaldehyde are ALDH2 (KM<1µM) > ALDH1B1 (KM 30µM) > ALDH1A1 (KM 50-
180 µM) [14]. ALDH2 is the predominant isoform involved in acetaldehyde detoxification in 
the liver. A common polymorphism of ALDH2 in Asians is linked to an increased risk of 
cancers of the upper aerodigestive tract and colorectum [12].  
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ALDH1B1 is highly expressed in the gastrointestinal epithelium and has been proposed to 
play an important role in acetaldehyde detoxification in the intestine [15, 16]. A 
polymorphism of ALDH1B1 with reduced activity [17] has been reported to be associated 
with drinking habits and alcohol sensitivity in Caucasians [18, 19]. Recently, Aldh1b1 
knockout mice were found to have increased plasma acetaldehyde levels after a single dose 
of ethanol [16]. 
In order to find direct evidence for genotoxic effects of ethanol in the intestine, along with 
mechanistic insights into the roles of acetaldehyde and Aldh1b1, we examined 
tumourigenesis in wildtype mice as well as in mice with Aldh1b1 depletion after long-term 
ethanol treatment. 
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Materials and Methods 
Long-term ethanol treatment of mice 
All experiments described in this study were performed under a project licence issued under 
the United Kingdom Home Office Animals (Scientific Procedures) Act 1986. 
Aldh1b1tm2a(EUCOMM)Wtsi mice were sourced from the EUCOMM project [20] and maintained 
on a C57BL/6 background. The “knockout-first” allele tm2a contains a lacZ promoterless 
trapping cassette inserted into the intron of the Aldh1b1 gene and a LoxP site in exon 2, 
which disrupt gene function. 
Homozygous Aldh1b1tm2a(EUCOMM)Wtsi mice (abbreviated to Aldh1b1tm2a hereafter) and 
wildtype littermates received either normal drinking water or ethanol in drinking water ad 
libitum for one year, starting at an age of 6-7 weeks (n=15 males and females in equal 
numbers). Ethanol treatment started with one month of 10% (v/v) ethanol in drinking water, 
followed by one month of 15% (v/v) ethanol in drinking water and 20% (v/v) ethanol in 
drinking water for the remaining ten months (Figure S1).  
Western Blot analysis 
Protein expression in intestinal epithelial cell lysates [21] was analysed by Western Blot 
using anti-Gapdh (#2118, Cell Signalling) and anti-Aldh1b1 (15560-1-AP, Proteintech) 
antibodies as detailed in Supplementary material and methods. 
Acetaldehyde assay 
Plasma was prepared from heparinised blood by 15 min centrifugation with 3,000g at 4°C 
immediately after withdrawal, snap-frozen on dry ice and stored at -80°C until analysis. 
Plasma acetaldehyde concentrations were determined using an enzymatic acetaldehyde 
assay kit (K-ACHYD, Megazyme) according to the manufacturer’s instructions. 
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Histology and immunohistochemistry 
Immunohistochemistry using rabbit anti-Aldh1b1 (15560-1-AP, Proteintech), rabbit anti-
Aldh2 (AB PB9472, Picoband), rabbit anti-Aldh1a1 (ab52492, abcam), rabbit anti-Ki67 
(ab16667, abcam), rabbit anti-P53 (CM1, gift from Phil Coates, [22]), rabbit anti-phospho-
histone H2A.X (Ser139) (γH2AX) (#2577, Cell Signaling) and rabbit anti-Cyp2e1 (ADI-100-
MFO, Enzo Life Sciences) primary antibodies is described in Supplementary material and 
methods along with details on antibody validation and quantitative analysis of 
immunostaining signals. 
Statistical analysis 
Data were analysed using GraphPad Prism® 6 software (version 6.04) and are shown as 
either mean or dot plot with SD error bars. Groups were compared using unpaired, two-tailed 
Student’s t-test or Mann-Whitney test as appropriate, or two-way ANOVA with Bonferroni’s 
multiple comparisons correction test, as detailed in the figure legends. Tumour incidence is 
depicted as bar charts and was analysed using Fisher’s exact test. Differences between 
groups were considered significant if p ≤ 0.05. 
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Results 
Ethanol treatment of mice 
Ethanol administration in drinking water mimics human patterns of ethanol intake, but 
ethanol clearance in mice is five times faster than in humans, so a high ethanol consumption 
is required in order to observe the same toxicity and pathological effects as in humans [23-
26]. C57BL6 mice have been shown to consume concentrations of up to 18% v/v ethanol 
voluntarily [27, 28], so the strain is well suited for ethanol administration in drinking water. In 
the present study, acceptance of ethanol in drinking water was good and mice consumed 
between 3.5-4.5 ml of liquid containing 10-20% v/v ethanol per day (Figure S2A). Whereas 
body weights of females did not differ, ethanol-fed wildtype and Aldh1b1tm2a males had 
significantly lower body weights than respective water-treated males starting from Week 27 
in Aldh1b1tm2a and Week 35 in wildtype mice (Figure S2B, C). 
Expression of ethanol-metabolising enzymes 
Protein expression of the Aldh isoforms with highest affinity for acetaldehyde, Aldh2, 
Aldh1b1 and Aldh1a1 [14, 29], was analysed in the mouse intestines by 
immunohistochemistry. Aldh2 had a cytosolic expression pattern and was expressed 
ubiquitously in the small and large intestines (Figure 1A-D). Aldh1b1 expression in wildtype 
mice was mostly confined to intestinal epithelial cells. The granular, cytosolic 
immunostaining was strongest in crypt epithelial cells and diminished towards the villus tip 
in the small intestines (Figure 1E). A similar gradient was observed in the distal and mid 
large intestines, with the highest staining intensity in crypt bases, decreasing towards the 
surface (Figure 1G), whereas immunostaining intensity of intestinal epithelial cells was 
uniform along the crypt axis of the proximal colon (not shown). An opposite gradient was 
observed for Aldh1a1 expression. Aldh1a1 immunostaining in the small intestines was 
cytosolic, and was confined exclusively to villus epithelial cells with no expression in the 
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crypt epithelium (Figure 1I, J). Likewise, in the large intestines, Aldh1a1 expression was 
confined to epithelial cells of the upper half of the crypt of the proximal and mid colon, 
whereas crypt bases were devoid of immunostaining (Figure 1K, L). Staining intensity 
decreased from proximal to distal large intestine. 
Aldh1b1tm2a murine intestines were mostly devoid of Aldh1b1 immunostaining. However, 
occasional single crypts and clusters of crypts in the small and large intestines were found 
to have a faint residual granular cytosolic immunostaining for Aldh1b1, which was strongest 
in crypts / crypt bases of the small / large intestines, thus exactly mimicking the expression 
pattern in wildtype murine intestines (Figure 1F, H). No compensatory up-regulation of Aldh2 
or Aldh1a1 expression was observed by immunohistochemistry in Aldh1b1tm2a mice treated 
with water (Fig. 1B, D, J, L) or ethanol (not shown) and ethanol did not influence Aldh2, 
Aldh1b1 or Aldh1a1 immunostaining intensity in the small or large intestines of wildtype or 
Aldh1b1tm2a mice (not shown). 
As the Aldh1b1 immunostaining pattern in Aldh1b1tm2a intestines suggested patchy residual 
expression, we analysed Aldh1b1 expression in isolated intestinal epithelium by Western 
Blot, loading four times as much protein of Aldh1b1tm2a than of wildtype samples in order to 
detect even low levels of residual protein expression. A weak band was observed, 
confirming very low level residual Aldh1b1 protein expression in Aldh1b1tm2a mouse 
intestinal epithelial cells (Figure 2), indicating that this mouse is a hypomorph rather than 
complete knockout of Aldh1b1 expression. 
Cyp2e1 is involved in ethanol metabolism in the liver, where it is thought to play a central 
role in adverse ethanol effects, and a similar role in the intestines has been suggested [11, 
13]. Immunohistochemical Cyp2e1 analysis verified enhanced Cyp2e1 protein expression 
in the ethanol-treated liver, as described in the literature [30]. We detected increased 
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Cyp2e1 immunostaining in livers of ethanol-treated mice, but only very faint immunostaining 
in the intestines with no apparent effect of ethanol or Aldh1b1 depletion (Figure S3). 
Effects of ethanol treatment on plasma acetaldehyde levels, tissue morphology, 
proliferation and DNA damage 
Adverse effects of acetaldehyde produced during ethanol metabolism are one of the 
proposed carcinogenic mechanisms of ethanol consumption [11]. ALDH1B1 is highly 
expressed in the human and murine intestines [15, 31] and has been suggested to play a 
role in intestinal ethanol metabolism [15, 16]. Aldh1b1 knockout mice have previously been 
shown to have higher plasma acetaldehyde levels than wildtypes after a single dose of 
ethanol [16], but no long-term ethanol treatments have been performed yet. By analysing 
Aldh1b1tm2a mice, we aimed to clarify the importance of Aldh1b1 in ethanol metabolism and 
to elucidate the role of acetaldehyde in intestinal damage related to ethanol consumption. 
Plasma acetaldehyde levels did not differ in water- and ethanol-treated wildtype mice, but 
there was a significant increase in plasma acetaldehyde levels in ethanol-treated 
Aldh1b1tm2a mice, compared with water-treated Aldh1b1tm2a mice and with ethanol-treated 
wildtype mice (Figure 3). 
During histopathological analysis of H&E-stained sections of liver, pancreas, oesophagus, 
stomach and caecum of water- and ethanol-treated wildtype and Aldh1b1tm2a mice, no 
abnormalities were found to be associated with either genotype or treatment. Intestinal 
morphology was analysed using H&E-stained swiss rolls of the small and large intestines. 
In accordance with a previous analysis of untreated Aldh1b1 knockout mice [16], we found 
no abnormalities in water-treated wildtype or Aldh1b1tm2a mice. However, there was an 
increased number of branching or budding crypts in the large intestines of some ethanol-
treated animals of both genotypes (Figure S4). There were no apparent differences in 
intestinal epithelial cells with apoptotic morphology [32] between the groups, but ethanol-
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treated wildtype and Aldh1b1tm2a mice showed more mitotic cells in higher regions of the 
crypt-villus axis of the small intestines or crypt axis of the large intestines (representative 
images in Figure S4). To quantify effects on proliferation, the length of the zone of epithelial 
cells with nuclear immunostaining for the proliferation marker Ki67 in relation to the total 
crypt length was determined (Figure 4). There were no significant differences in intestinal 
Ki67-positive zones between any of the groups in the distal colon and rectum (not shown), 
however the proliferative, Ki67-positive zones in the proximal small and large intestines of 
ethanol-treated wildtype mice were significantly longer than in water-treated wildtype mice. 
This effect was more pronounced in ethanol-treated Aldh1b1tm2a mice, where the Ki67-
positive zones were significantly longer compared with water-treated Aldh1b1tm2a in the 
proximal small and large intestines and also in the distal small intestines and mid colon. 
Moreover, the Ki67-positive zones in the proximal and distal small intestines and in the mid 
colon were significantly longer in ethanol-treated Aldh1b1tm2a mice compared with ethanol-
treated wildtype mice, indicating a higher susceptibility of Aldh1b1tm2a mice to ethanol-
induced intestinal hyperproliferation. 
We further assessed C-terminally phosphorylated histone H2AX (termed γH2AX) 
immunostaining. This marker for DNA double-strand breaks arises quickly after DNA 
damage and can be detected for several months thereafter, making it a suitable long-term 
marker [33]. There were no differences in the small intestines, but a highly significant 
increase in γH2AX-positive nuclei was found throughout the epithelium of the large 
intestines of ethanol-treated wildtype and Aldh1b1tm2a mice compared with the respective 
water-treated groups (Figure 4). 
Tumour development 
Irrespective of genotype or treatment, 60-85% of females and 25-50% of males developed 
lymphoma (Figure S5), a common background lesion in the C57BL6 strain [34]. 4/14 
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wildtype mice and 4/15 Aldh1b1tm2a mice developed intestinal epithelial tumours after one 
year of ethanol treatment. One tumour was located in the proximal small intestine, whereas 
all other intestinal tumours in both groups were either found at the transition of the proximal 
colon to the mid colon or at the proximal end of the colon just after the caecum (Figure 5). 
One ethanol-treated Aldh1b1tm2a mouse developed hepatocellular carcinoma and one 
water-treated wildtype mouse was diagnosed with a benign squamous papilloma of the 
oesophagus during histopathological analysis. No tumours at other sites were found during 
necropsy or histopathological analysis. The effect of ethanol on intestinal tumour 
development was significant (p<0.05) in the wildtype and there was a trend (p=0.0996) in 
Aldh1b1tm2a mice. Ethanol effects on intestinal tumourigenesis were highly significant when 
combining both wildtype and Aldh1b1tm2a mice in order to analyse the ethanol effect 
irrespective of genotype (Figure 5, Table 1). There was no difference between ethanol-
treated wildtype and Aldh1b1tm2a mice regarding tumour number or size (Figure S5). 
Most intestinal tumours were adenomas with low-grade (mild to moderate) dysplasia. Some 
tumours of the ethanol-fed Aldh1b1tm2a mice displayed signs of focal high-grade dysplasia 
and showed foci of invasive adenocarcinoma (Figure S5). Adenomatous crypts were 
characterised by extensive nuclear Ki67 immunostaining. Many tumours had areas with 
widespread nuclear p53-immunostaining that showed an increased intensity compared with 
normal intestinal epithelium. These areas often contained more nuclei with γH2AX positive 
nuclei. (Figure 6, Figure S6) 
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Discussion  
Rodent studies (overview in [1]) prompted the classification of ethanol as a carcinogen in 
experimental animals in different locations, including the colorectum. However, evidence for 
CRC was derived exclusively from rodent models with additional carcinogen treatment or 
genetic inactivation of tumour suppressor genes (e.g. Apc), whereas intestinal 
tumourigenesis after ethanol treatment alone has not been reported previously [7]. In the 
current study, we found for the first time that long-term ethanol treatment of mice leads to 
intestinal tumour development. Possible reasons why this has not been reported in previous 
studies include: i) ethanol treatment duration usually being much shorter than one year; and 
ii) less ethanol consumption in the few existing long-term studies despite the rapid ethanol 
elimination in rodents that necessitates higher ethanol consumption to observe the same 
physiological and pathological effects as in humans [26]. In addition, none of the publications 
mentioned that intestines were longitudinally opened, stained and analysed as whole mount 
specimens, so it is possible that intestinal tumours were missed. 
Besides other mechanisms, the two predominant routes previously suggested to explain 
pro-carcinogenic properties of ethanol are related to acetaldehyde and to Cyp2e1 induction, 
which can both lead to genotoxic damage [1, 7, 35, 36]. Pro-carcinogenic functions of 
Cyp2e1 include generation of reactive oxygen species which can result in oxidative DNA 
damage, stimulation of proliferation, procarcinogen activation and perturbation of retinoic 
acid metabolism [11, 35]. Acetaldehyde leads to genotoxic damage via DNA adducts and 
induces hyperproliferation [37, 38]. N2-ethylidenedeoxyguanosine adducts (stabilised and 
detected by reduction to N2-ethyldeoxyguanosine) are abundant and weakly mutagenic and 
have been used as a biomarker for ethanol-induced DNA damage. N2-
propanodeoxyguanosine adducts are less abundant and could not be detected in all 
biomarker studies of ethanol exposure, however they are highly mutagenic, causing DNA 
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inter- and intra-strand crosslinks as well as DNA-protein crosslinks. Mutations can also be 
caused by ethenobase adducts, related to lipid peroxidation stimulated by acetaldehyde or 
also by reactive oxygen species generated by Cyp2e1 [1, 37, 38]. Mechanisms related to 
Cyp2e1 and oxidative stress are mostly described in relation to ethanol-associated liver 
damage [35], whereas most evidence and mechanistic details relating to acetaldehyde are 
discussed for cancers of the upper aerodigestive tract [38]. Both mechanisms have been 
suggested to play a role in intestinal carcinogenesis [7, 11, 39]. 
Cyp2e1 is highly expressed in the liver, but protein expression in the intestine is 
controversial [40, 41]. Basal expression of Cyp2e1 protein has been reported in some 
studies for human [42] and rodent [13, 43, 44] colon and rat small intestines [45], whereas 
other studies found no evidence of Cyp2e1 protein expression in human or rodent colon [46, 
47] or human [48, 49] or rodent [50] small intestines. Cyp2e1 protein induction by ethanol 
has been detected in rodent colon [13, 43, 45] and small intestines [45, 51] suggesting a 
role for Cyp2e1 in intestinal ethanol effects. We found increased Cyp2e1 immunostaining in 
ethanol-treated wildtype and Aldh1b1tm2a livers. However, we could not detect any notable 
differences in the intestines, so an involvement of Cyp2e1 in intestinal ethanol effects is 
unlikely in our model. 
ALDH2 is crucial for acetaldehyde metabolism in human liver, and ethanol-treated Aldh2 
knockout mice were found to have increased plasma acetaldehyde levels compared with 
wildtypes [52]. They were also shown to have higher N2-ethylidenedeoxyguanosine levels 
than wildtypes in the liver [53], stomach [54], oesophagus [55, 56], tongue and 
submandibular gland [55] after ethanol treatment. We have previously shown that mice with 
synchronous disruption of the Fanconi anaemia pathway and Aldh2 were most susceptible 
to ethanol-induced haematopoietic toxicity, with marrow aplasia and leukaemia resulting 
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from DNA damage in haematopoietic cells, and foetuses were more susceptible to ethanol 
teratogenicity [36, 57].  
Aldh1b1 has been proposed to play an important role in acetaldehyde detoxification in the 
intestine [15, 16]. We observed the highest Aldh1b1 expression in the proliferative 
compartments of the murine small and large intestinal epithelium. Previously published 
figures [15] showed a similar pattern in large intestinal crypts and were interpreted as 
indicating stem cell positivity. It is tempting to speculate that Aldh1b1 might be particularly 
important for protection of the crypt basal stem cell and proliferating compartments of the 
intestinal epithelium (which is most prone to tumour formation) from genotoxic DNA damage 
by acetaldehyde after ethanol consumption. We have found increased plasma acetaldehyde 
levels in ethanol-treated Aldh1b1tm2a mice compared with ethanol-treated wildtypes in 
accordance with previous observations in Aldh1b1 knockout mice [16] and we hypothesise 
that Aldh1b1 deletion might also lead to locally increased acetaldehyde levels in the 
proliferative intestinal epithelium after ethanol consumption. 
The gene trap approach of the knockout first strategy that was applied to generate 
Aldh1b1tm2a mice [20] can generate hypomorphs as well as complete gene knockouts, for 
example when alternative splicing occurs over the gene trap cassette [58-60]. In the case of 
the Aldh1b1tm2a allele, the entire protein coding region is contained in Aldh1b1 exon 2 and 
is not disrupted by either the transgene cassette or distal LoxP site, which explains the low 
level residual protein expression that we observed, indicating that this is a hypomorph with 
very low intestinal Aldh1b1 expression. Accordingly, Aldh1b1tm2a mice might not display the 
maximum effect of a complete Aldh1b1 deletion. However, residual expression in the 
intestines was at a very low level and only present in occasional single crypts or small 
patches of crypts and most of the intestinal epithelium was devoid of staining. Moreover, the 
increased plasma acetaldehyde levels indicated functional effects of Aldh1b1 marked 
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reduction, making Aldh1b1tm2a mice a useful model for studying the role of acetaldehyde and 
Aldh1b1 depletion. 
Increased γH2AX levels have been detected in ethanol-treated mice with a combination of 
Aldh2 deletion and a defective Fanconi anaemia pathway [36] and in acetaldehyde treated 
cells [61]. DNA double-strand breaks might arise from N2-propano-2’-deoxyguanosine DNA-
acetaldehyde adducts after ethanol treatment, producing DNA interstrand crosslinks and 
DNA-protein crosslinks [37]. We detected a highly significant increase in nuclear γH2AX 
immunostaining by ethanol treatment in the entire large intestinal epithelium, but not in the 
small intestinal epithelium of wildtype and Aldh1b1tm2a mice, indicating genotoxic damage 
after ethanol consumption. Furthermore, a co-localisation of Ki67, γH2AX and p53 
immunostaining in adenomatous crypts reflected the DNA damage and response in ethanol-
induced tumours. There was no genotype difference in γH2AX immunostaining, tumour 
incidence, number or size between ethanol-treated wildtype and Aldh1b1tm2a mice. 
However, some intestinal tumours of Aldh1b1tm2a mice had evidence of high-grade 
dysplasia, with focal invasive adenocarcinoma, whereas wildtype tumours displayed only 
low-grade dysplasia. The difference in local cellular acetaldehyde levels might not have 
been sufficient to result in large detectable differences in DNA damage, while acetaldehyde 
still affected intestinal proliferation and tumour progression. 
Hepatic ethanol-induced hyperproliferation has been linked with increased activator protein-
1 levels and retinoic acid depletion related to the induction of Cyp2e1 [11, 35, 62-64]. 
Stimulation of proliferation by ethanol has also been reported in the oesophagus [65], small 
intestines [66] and large intestines [66-68] of ethanol-treated rats as well as in human 
alcoholics [69], but has not been detected in the distal small intestine of ethanol-treated 
ApcMin mice [8]. Increased acetaldehyde levels after ethanol consumption have been 
suggested to play a role in ethanol-induced hyperproliferation [70], as acetaldehyde 
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treatment of rats induced proliferation of the upper gastrointestinal tract mucosa [71] and 
large intestinal proliferation in ethanol-treated rats was found to correlate with mucosal 
acetaldehyde levels [68]. 
In the current study, we found histological features of increased intestinal epithelial 
proliferation after ethanol consumption, such as increased and ectopic mitotic figures and 
crypt branching or budding, and this was confirmed by observing longer Ki67-positive zones 
in ethanol-treated murine intestines, which were significantly longer in ethanol-treated 
Aldh1b1tm2a mice compared with ethanol-treated wildtypes. This increase in ethanol-induced 
intestinal hyperproliferation after depletion of the acetaldehyde-metabolising enzyme 
Aldh1b1 provides the first direct causal evidence for a role of acetaldehyde in intestinal 
hyperproliferation after ethanol consumption. It further shows that Aldh1b1 contributes to the 
protection of the intestinal epithelium from damage related to ethanol consumption.  
In conclusion, we show for the first time that long-term ethanol consumption without 
additional carcinogen treatment or prior tumour suppressor gene inactivation, leads to 
intestinal hyperproliferation, DNA damage and intestinal tumourigenesis in wildtype and 
Aldh1b1-depleted mice. Interestingly, apart from one small intestinal tumour, all intestinal 
tumours were found in the mid and proximal colon, which are the same sites where ethanol-
induced hyperproliferation was observed. Aldh1b1 depletion and the related increase in 
blood acetaldehyde (together with a likely local increase in acetaldehyde levels within the 
intestinal epithelium) aggravated both intestinal hyperproliferation and histopathological 
features of tumour progression, but did not affect tumour incidence. Thus, ethanol and its 
metabolite acetaldehyde appear to act as both carcinogen and tumour promotor – 
acetaldehyde acts at lower levels in wildtype and higher levels in Aldh1b1 depleted mice to 
promote intestinal hyperproliferation at lower and higher levels respectively, indicating a 
tumour promoter role for acetaldehyde. Ethanol / acetaldehyde acting as DNA damaging 
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carcinogen appears to have similar effects on intestinal tumour initiation in both wildtype and 
Aldh1b1 depleted mice. Furthermore, we provide evidence that increased levels of 
acetaldehyde (in Aldh1b1 depleted mice) appear to be important in intestinal tumour 
progression. 
Page 19 of 32 
 
Acknowledgements 
We thank KJ Patel for providing mouse models, P Coates for providing the p53 CM1 
antibody, A Cederbaum, AP Kipp and N Oberbeck for providing FFPE specimens for 
antibody validation and H Caldwell and E McLay for technical support and sample 
processing. 
Page 20 of 32 
 
Conflict of interest declaration 
The authors declare that there are no conflicts of interest. 
 
 
Page 21 of 32 
 
Abbreviations 
ADH: alcohol dehydrogenase, ALDH: aldehyde dehydrogenase; Aldh1b1tm2a: 
Aldh1b1tm2a(EUCOMM)Wtsi; APC: adenomatous polyposis coli; CRC: colorectal cancer; 
CYP2E1: cytochrome P450 2e1; FFPE: formalin-fixed, paraffin-embedded; LI: large 
intestines, SI: small intestines, WT: wildtype 
Page 22 of 32 
 
Statement of author contributions 
MJA and MFM conceived the experiments. MFM and YZ carried out experiments. MJA and 
MFM carried out histopathological analysis and MFM analysed the data and produced the 
figures. MFM and MJA wrote the manuscript. DJA provided the mouse model, gave 
experimental advice and revised the manuscript. 
 
Page 23 of 32 
 
Reference list 
1. IARC. Alcohol Consumption and Ethyl Carbamate. International Agency for Research 
on Cancer, WHO: Lyon, France 2010. 
2. Cho E, Smith-Warner SA, Ritz J, et al. Alcohol Intake and Colorectal Cancer: A 
Pooled Analysis of 8 Cohort Studies. Ann Intern Med 2004; 140: 603-613. 
3. Moskal A, Norat T, Ferrari P, et al. Alcohol intake and colorectal cancer risk: A dose–
response meta‐analysis of published cohort studies. Int J Cancer 2007; 120: 664-
671. 
4. Wang Y, Duan H, Yang H, et al. A pooled analysis of alcohol intake and colorectal 
cancer. Int J Clin Exp Med 2015; 8: 6878-6889. 
5. Park JY, Mitrou PN, Keen J, et al. Lifestyle factors and p53 mutation patterns in 
colorectal cancer patients in the EPIC-Norfolk study. Mutagenesis 2010; 25: 351-358. 
6. Gay LJ, Mitrou PN, Keen J, et al. Dietary, lifestyle and clinicopathological factors 
associated with APC mutations and promoter methylation in colorectal cancers from 
the EPIC-Norfolk study. J Pathol 2012; 228: 405-415. 
7. Oyesanmi O, Snyder D, Sullivan N. Alcohol Consumption and Cancer Risk: 
Understanding Possible Causal Mechanisms for Breast and Colorectal Cancers. 
Evidence Report/Technology Assessment No. 197. Agency for Healthcare Research 
and Quality: Rockville, MD 2010. 
8. Roy HK, Gulizia JM, Karolski WJ, et al. Ethanol promotes intestinal tumorigenesis in 
the MIN mouse. Cancer Epidemiol Biomarkers Prev 2002; 11: 1499-1502. 
9. Wimberly AL, Forsyth CB, Khan MW, et al. Ethanol-Induced Mast Cell-Mediated 
Inflammation Leads to Increased Susceptibility of Intestinal Tumorigenesis in the 
APCΔ468 Min Mouse Model of Colon Cancer. Alcohol Clin Exp Res 2013; 37: E199-
E208. 
10. Pöschl G, Stickel F, Wang XD, et al. Alcohol and cancer: genetic and nutritional 
aspects. Proc Nutr Soc 2004; 63: 65-71. 
11. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat 
Rev Cancer 2007; 7: 599-612. 
12. Seitz HK, Stickel F. Acetaldehyde as an underestimated risk factor for cancer 
development: role of genetics in ethanol metabolism. Genes Nutr 2010; 5: 121-128. 
13. Forsyth CB, Voigt RM, Shaikh M, et al. Role for intestinal CYP2E1 in alcohol-induced 
circadian gene-mediated intestinal hyperpermeability. Am J Physiol Gastrointest 
Liver Physiol 2013; 305: G185-G195. 
14. Marchitti SA, Brocker C, Stagos D, et al. Non-P450 aldehyde oxidizing enzymes: the 
aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008; 4: 697-
720. 
15. Stagos D, Chen Y, Brocker C, et al. Aldehyde Dehydrogenase 1B1: Molecular 
Cloning and Characterization of a Novel Mitochondrial Acetaldehyde-Metabolizing 
Enzyme. Drug Metab Dispos 2010; 38: 1679-1687. 
16. Singh S, Chen Y, Matsumoto A, et al. ALDH1B1 links alcohol consumption and 
diabetes. Biochem Biophys Res Commun 2015; 463: 768-773. 
17. Jackson BC, Reigan P, Miller B, et al. Human ALDH1B1 Polymorphisms may Affect 
the Metabolism of Acetaldehyde and All-trans retinaldehyde—In Vitro Studies and 
Computational Modeling. Pharm Res 2014; 32: 1648-1662. 
18. Husemoen LL, Fenger M, Friedrich N, et al. The association of ADH and ALDH gene 
variants with alcohol drinking habits and cardiovascular disease risk factors. Alcohol 
Clin Exp Res 2008; 32: 1984-1991. 
Page 24 of 32 
 
19. Linneberg A, Gonzalez-Quintela A, Vidal C, et al. Genetic determinants of both 
ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking 
behaviour among Scandinavians. Clin Exp Allergy 2010; 40: 123-130. 
20. Skarnes WC, Rosen B, West AP, et al. A conditional knockout resource for the 
genome-wide study of mouse gene function. Nature 2011; 474: 337-342. 
21. Perreault N, Beaulieu J-F. Primary Cultures of Fully Differentiated and Pure Human 
Intestinal Epithelial Cells. Exp Cell Res 1998; 245: 34-42. 
22. Coates PJ, Virginia M, Appleyard CL, et al. Differential Contextual Responses of 
Normal Human Breast Epithelium to Ionizing Radiation in a Mouse Xenograft Model. 
Cancer Res 2010; 70: 9808-9815. 
23. Abel EL. Fetal alcohol syndrome: behavioral teratology. Psychol Bull 1980; 87: 29. 
24. Dole VP, Gentry RT. Toward an analogue of alcoholism in mice: scale factors in the 
model. Proc Natl Acad Sci U S A 1984; 81: 3543-3546. 
25. Holmes RS, Duley JA, Algar EM, et al. Biochemical and genetic studies on enzymes 
of alcohol metabolism: the mouse as a model organism for human studies. Alcohol 
Alcohol 1986; 21: 41-56. 
26. Brandon-Warner E, Schrum LW, Schmidt CM, et al. Rodent models of alcoholic liver 
disease: of mice and men. Alcohol 2012; 46: 715-725. 
27. Belknap JK, Crabbe JC, Young ER. Voluntary consumption of ethanol in 15 inbred 
mouse strains. Psychopharmacology (Berl) 1993; 112: 503-510. 
28. McMillen BA, Williams HL. Role of Taste and Calories in the Selection of Ethanol by 
C57BL/6NHsd and Hsd:ICR Mice. Alcohol 1998; 15: 193-198. 
29. Singh S, Arcaroli J, Thompson D, et al. Acetaldehyde and Retinaldehyde-
Metabolizing Enzymes in Colon and Pancreatic Cancers. In: Vasiliou V, Zakhari S, 
Seitz H, Hoek J, eds. Biological Basis of Alcohol-Induced Cancer. 1 ed. Springer: 
Cham 2015:281-294. 
30. Lu Y, Cederbaum AI. CYP2E1 and Oxidative Liver Injury by Alcohol. Free Radic Biol 
Med 2008; 44: 723-738. 
31. Alnouti Y, Klaassen CD. Tissue Distribution, Ontogeny, and Regulation of Aldehyde 
Dehydrogenase (Aldh) Enzymes mRNA by Prototypical Microsomal Enzyme 
Inducers in Mice. Toxicol Sci 2008; 101: 51-64. 
32. Hall PA, Coates PJ, Ansari B, et al. Regulation of cell number in the mammalian 
gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-3577. 
33. Siddiqui MS, François M, Fenech MF, et al. Persistent γH2AX: A promising molecular 
marker of DNA damage and aging. Mutat Res Rev Mutat Res 2015; 766: 1-19. 
34. Ward JM. Lymphomas and leukemias in mice. Exp Toxicol Pathol 2006; 57: 377-381. 
35. Seitz H, Mueller S. Alcohol and Cancer: An Overview with Special Emphasis on the 
Role of Acetaldehyde and Cytochrome P450 2E1. In: Vasiliou V, Zakhari S, Seitz KH, 
Hoek BJ, eds. Biological Basis of Alcohol-Induced Cancer. 1 ed. Springer 
International Publishing: Cham 2015:59-70. 
36. Langevin F, Crossan GP, Rosado IV, et al. Fancd2 counteracts the toxic effects of 
naturally produced aldehydes in mice. Nature 2011; 475: 53-58. 
37. Brooks PJ, Zakhari S. Acetaldehyde and the genome: Beyond nuclear DNA adducts 
and carcinogenesis. Environ Mol Mutagen 2014; 55: 77-91. 
38. Balbo S, Brooks PJ. Implications of Acetaldehyde-Derived DNA Adducts for 
Understanding Alcohol-Related Carcinogenesis. In: Vasiliou V, Zakhari S, Seitz KH, 
Hoek BJ, eds. Biological Basis of Alcohol-Induced Cancer. 1 ed. Springer 
International Publishing: Cham 2015:71-88. 
39. Seitz HK, Wang XD. The Role of Cytochrome P450 2E1 in Ethanol-Mediated 
Carcinogenesis. Subcell Biochem 2013; 67: 131-143. 
Page 25 of 32 
 
40. Thelen K, Dressman JB. Cytochrome P450‐mediated metabolism in the human gut 
wall. J Pharm Pharmacol 2009; 61: 541-558. 
41. Kaminsky LS, Zhang Q-Y. The small intestine as a xenobiotic-metabolizing organ. 
Drug Metab Dispos 2003; 31: 1520-1525. 
42. Bergheim I, Bode C, Parlesak A. Distribution of cytochrome P450 2C, 2E1, 3A4, and 
3A5 in human colon mucosa. BMC Clin Pharmacol 2005; 5: 4. 
43. Hakkak R, Korourian S, Ronis MJJ, et al. Effects of diet and ethanol on the expression 
and localization of cytochromes P450 2E1 and P450 2C7 in the colon of male rats. 
Biochem Pharmacol 1996; 51: 61-69. 
44. Oyama T, Isse T, Kagawa N, et al. Tissue-distribution of aldehyde dehydrogenase 2 
and effects of the ALDH2 gene-disruption on the expression of enzymes involved in 
alcohol metabolism. Front Biosci 2005; 10: 951-960. 
45. Shimizu M, Lasker JM, Tsutsumi M, et al. Immunohistochemical localization of 
ethanol-inducible P450IIE1 in the rat alimentary tract. Gastroenterology 1990; 99: 
1044-1053. 
46. de Waziers I, Cugnenc PH, Yang CS, et al. Cytochrome P 450 isoenzymes, epoxide 
hydrolase and glutathione transferases in rat and human hepatic and extrahepatic 
tissues. J Pharmacol Exp Ther 1990; 253: 387-394. 
47. Ding X, Kaminsky LS. Human Extrahepatic Cytochromes P450: Function in 
Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory 
and Gastrointestinal Tracts. Annu Rev Pharmacol Toxicol 2003; 43: 149-173. 
48. Zhang Q-Y, Dunbar D, Ostrowska A, et al. Characterization of Human Small Intestinal 
Cytochromes P-450. Drug Metab Dispos 1999; 27: 804-809. 
49. Gröer C, Busch D, Patrzyk M, et al. Absolute protein quantification of clinically 
relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass 
spectrometry-based targeted proteomics. J Pharm Biomed Anal 2014; 100: 393-401. 
50. Emoto C, Yamazaki H, Yamasaki S, et al. Characterization of cytochrome P450 
enzymes involved in drug oxidations in mouse intestinal microsomes. Xenobiotica 
2000; 30: 943-953. 
51. Abdelmegeed MA, Banerjee A, Jang S, et al. CYP2E1 potentiates binge alcohol-
induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med 2013; 65: 
1238-1245. 
52. Kiyoshi A, Weihuan W, Mostofa J, et al. Ethanol metabolism in ALDH2 knockout mice 
– Blood acetate levels. Leg Med 2009; 11, Supplement 1: S413-S415. 
53. Matsuda T, Matsumoto A, Uchida M, et al. Increased formation of hepatic N2-
ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout 
mice treated with ethanol. Carcinogenesis 2007; 28: 2363-2366. 
54. Nagayoshi H, Matsumoto A, Nishi R, et al. Increased formation of gastric N2-
ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout 
mice treated with ethanol. Mutat Res Genet Toxicol Environ Mutagen 2009; 673: 74-
77. 
55. Yu HS, Oyama T, Matsuda T, et al. The effect of ethanol on the formation of N2-
ethylidene-dG adducts in mice: Implications for alcohol-related carcinogenicity of the 
oral cavity and esophagus. Biomarkers 2012; 17: 269-274. 
56. Yukawa Y, Ohashi S, Amanuma Y, et al. Impairment of aldehyde dehydrogenase 2 
increases accumulation of acetaldehyde-derived DNA damage in the esophagus 
after ethanol ingestion. Am J Cancer Res 2014; 4: 279-284. 
57. Garaycoechea JI, Crossan GP, Langevin F, et al. Genotoxic consequences of 
endogenous aldehydes on mouse haematopoietic stem cell function. Nature 2012; 
489: 571-575. 
Page 26 of 32 
 
58. The International Mouse Knockout C. A Mouse for All Reasons. Cell 2007; 128: 9-
13. 
59. Adams DJ, van der Weyden L. Contemporary approaches for modifying the mouse 
genome. Physiological Genomics 2008; 34: 225-238. 
60. Guan C, Ye C, Yang X, et al. A review of current large‐scale mouse knockout efforts. 
Genesis 2010; 48: 73-85. 
61. Kotova N, Vare D, Schultz N, et al. Genotoxicity of alcohol is linked to DNA 
replication-associated damage and homologous recombination repair. 
Carcinogenesis 2013; 34: 325-330. 
62. Wang XD, Liu C, Chung J, et al. Chronic alcohol intake reduces retinoic acid 
concentration and enhances AP‐1 (c‐Jun and c‐Fos) expression in rat liver. 
Hepatology 1998; 28: 744-750. 
63. Liu C, Russell RM, Seitz HK, et al. Ethanol enhances retinoic acid metabolism into 
polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 
2001; 120: 179-189. 
64. Ye Q, Lian F, Chavez PR, et al. Cytochrome P450 2E1 inhibition prevents hepatic 
carcinogenesis induced by diethylnitrosamine in alcohol-fed rats. Hepatobiliary Surg 
Nutr 2012; 1: 5-18. 
65. Simanowski UA, Suter P, Stickel F, et al. Esophageal epithelial hyperproliferation 
following long-term alcohol consumption in rats: effects of age and salivary gland 
function. J Natl Cancer Inst 1993; 85: 2030-2033. 
66. Pronko P, Bardina L, Satanovskaya V, et al. Effect of chronic alcohol consumption 
on the ethanol- and acetaldehyde-metabolizing systems in the rat gastrointestinal 
tract. Alcohol Alcohol 2002; 37: 229-235. 
67. Simanowski UA, Seitz HK, Baier B, et al. Chronic ethanol consumption selectively 
stimulates rectal cell proliferation in the rat. Gut 1986; 27: 278-282. 
68. Simanowski UA, Suter P, Russell RM, et al. Enhancement of ethanol induced rectal 
mucosal hyper regeneration with age in F344 rats. Gut 1994; 35: 1102-1106. 
69. Simanowski UA, Homann N, Knühl M, et al. Increased rectal cell proliferation 
following alcohol abuse. Gut 2001; 49: 418-422. 
70. Seitz H, Simanowski U, Homann N, et al. Cell proliferation and its evaluation in the 
colorectal mucosa: effect of ethanol. Z Gastroenterol 1998; 36: 645-655. 
71. Homann N, Koivisto T, Nosova T, et al. Effects of Acetaldehyde on Cell Regeneration 
and Differentiation of the Upper Gastrointestinal Tract Mucosa. J Natl Cancer Inst 
1997; 89: 1692-1697. 
72. Koscielny G, Yaikhom G, Iyer V, et al. The International Mouse Phenotyping 
Consortium Web Portal, a unified point of access for knockout mice and related 
phenotyping data. Nucleic Acids Res 2014; 42: D802-D809. 
73. Koscielny G, Yaikhom G, Iyer V, et al. MGI:1919785 » Alleles » tm2a(EUCOMM)Wtsi.  
26 April 2016 [cited 12 September 2016]; Release: 4.3:[Available from: 
http://www.mousephenotype.org/data/alleles/MGI:1919785/tm2a%28EUCOMM%29
Wtsi 
 
 
 
Page 27 of 32 
 
Tables 
Table 1. 
Group Intestinal tumours Lymphoma Other 
tumours Number of 
tumour-
bearing 
mice (%) 
Tumour 
number per 
group 
Tumour type Number of 
tumour-
bearing mice 
(%) 
Wildtype, 
water 
0/15 0 na 7/15 (47%) 1 benign 
squamous 
papilloma of 
the 
oesophagus 
Aldh1b1tm2a, 
water 
0/15 0 na 9/15 (60%) 0 
Wildtype, 
ethanol 
4/14 (29%) 8 7 large intestinal 
adenomas, 1 
small intestinal 
adenoma 
7/14 (50%) 0 
Aldh1b1tm2a, 
ethanol 
4/15 (27%) 11 8 large intestinal 
adenomas and 3 
early adenocarci-
nomas of the 
large intestine 
8/15 (53%) 1 
hepatocellular 
carcinoma 
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Table and figure legends 
Table 1. 
Tumours in wildtype and Aldh1b1tm2a mice after 1 year of ethanol- or water-treatment. 
 
Figure 1. 
Representative images of Aldh immunostaining of the small intestines (A, B, E, F, I, J) and 
large intestines (C, D, G, H, K, L) of water-fed wildtype (A, C, E, G, I, K) and Aldh1b1tm2a (B, 
D, F, H, J, L) mice: Aldh2 (A-D), Aldh1b1 (E-H), Aldh1a1 (I-L) (scale bar 50 µm). Images F 
and H were chosen to represent focal areas with residual staining in Aldh1b1tm2a intestines. 
They are not representative for the overall immunostaining of the intestinal epithelium, which 
was mostly blank. Dashed lines indicate outlines of crypts and villi. Arrows show residual 
immunostaining in F and H and lack of immunostaining in K and L. 
 
Figure 2. 
Representative Western Blot analysis images of Aldh1b1 and Gapdh protein expression in 
isolated intestinal epithelial cells of the large intestine (A) and small intestine (B) of mice 
treated with 20% (v/v) ethanol in drinking water or regular drinking water for three weeks. 
5 µg of total protein were loaded for wildtype (WT) samples, whereas 20 µg protein were 
loaded for Aldh1b1tm2a (tm2a) samples in order to detect very low levels of residual Aldh1b1 
protein expression in Aldh1b1tm2a mice. C) Illustration of the Aldh1b1tm2a(EUCOMM)Wtsi targeted 
Aldh1b1 gene with “knockout first cassette” in Aldh1b1tm2a mice. Modified image from [72, 
73]. The protein coding region (light grey bar) is not interrupted by the loxP site within exon 
2. 
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Figure 3. 
Plasma acetaldehyde concentrations of water- and ethanol-treated wildtype (WT) and 
Aldh1b1tm2a mice. Data are shown as mean and SD error bars, n=7. Significant ethanol 
effects are denoted as ** p ≤ 0.01, and genotype effects are denoted as # p ≤ 0.05 as 
determined with unpaired, two-tailed Student’s t-tests. 
 
Figure 4. 
Representative images of Ki67 immunostaining of the small intestine (A-D) and colon (E-H) 
and of γH2AX immunostaining of the colon (I-L) of wildtype (A, B, E, F, I, J) and Aldh1b1tm2a 
(C, D, G, H, K, L) mice treated with water (A, C, E, G, I, K) or ethanol (B, D, F, H, J, L). Scale 
bar for A-D: 100µm. Scale bar for E-H: 50µm. Scale bar for I-L: 50µm. (M-P) Quantification 
of length of zone with Ki67-positive intestinal epithelial cell nuclei as percentage of total crypt 
length in wildtype and Aldh1b1tm2a mice treated with water or ethanol, in the proximal small 
intestine (M), distal small intestine (N), proximal colon (O) and mid colon (P). (Q) 
Quantification of nuclear γH2AX for the large intestine using a score from 0-3. Data are 
shown as dot plots with mean and SD error bars, n=14-15. Significant ethanol effects are 
denoted as * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 and genotype effects are denoted as 
# p ≤ 0.05 as determined with unpaired, two-tailed Student’s t-tests. 
 
Figure 5. 
Analysis of intestinal tumours. Representative images of tumour analysis of the large 
intestine with (A) whole mount image of methylene blue-stained large intestine. Sequential 
images were combined to produce a whole-length image. White arrowheads indicate 
tumours (scale bar: 5mm). Magnification (B) of tumours indicated in “(A)” (scale bar: 1mm). 
(C) H&E sections of intestinal tumours (scale bar: 500µm). (D) Bar chart of number of 
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wildtype and Aldh1b1tm2a mice that developed intestinal tumours after receiving ethanol in 
drinking water or regular drinking water for one year. Fisher’s exact test was calculated to 
compare ethanol effects separately in wildtype mice (* p ≤ 0.05) and in Aldh1b1tm2a mice 
(p=0.0996). E) Bar chart of ethanol effects irrespective of genotype. Ethanol-treated wildtype 
and Aldh1b1tm2a mice were combined into one group and compared with water-treated 
wildtype and Aldh1b1tm2a mice using Fisher’s exact test (** p ≤ 0.01). 
 
Figure 6. 
Representative immunostaining images of tumours of the large intestine of ethanol-treated 
Aldh1b1tm2a mice (A-F) and small intestine of an ethanol-treated wildtype mouse (G-I). 
Immunostaining for Ki67 (A, D, G), p53 (B, E, H) and γH2AX (C, F, I) (scale bar: 100µm). 
 
Figure S1. 
Experimental setup for long-term ethanol treatment of mice. Each group consisted of 15 
male and female Aldh1b1tm2a mice or 15 wildtype littermates that received either normal 
drinking water or ethanol in drinking water for one year starting at an age of 6-7 weeks. 
Ethanol treatment started with one month of 10% (v/v) ethanol in drinking water, followed by 
one month of 15% (v/v) ethanol in drinking water, and 20% (v/v) ethanol in drinking water 
for the remaining ten months. *One ethanol-treated wildtype mouse was found dead at an 
early time point and was excluded from the analysis. 
 
Figure S2. 
A) Mean liquid consumption per day of mice receiving regular drinking water or ethanol in 
drinking water. Liquid consumption per mouse was calculated from drinking water use per 
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cage over the entire duration of the experiment (n=4-6 cages with 2-5 mice each per 
treatment and sex, wildtype and Aldh1b1tm2a littermates were housed together). Data are 
shown for males and females as mean and SD error bars. Differences were evaluated using 
two-way ANOVA with Bonferroni’s multiple comparisons test. (B, C) Body weights of water- 
and ethanol-treated wildtype (WT) and Aldh1b1tm2a (tm2a) mice over the course of the 
experiment. Group means and SD error bars are shown for females (B) and males (C), n=7-
8. Differences were evaluated using two-way ANOVA with Bonferroni’s multiple 
comparisons test. Body weights of males were significantly different between water and 
ethanol-treated mice of the same genotype: 1) Body weights of ethanol-treated wildtype 
males were significantly lower than body weights of water-treated wildtype males in weeks: 
35 (*), 41(*), 42 (*), 43 (*), 44(*), 45 (*), 46 (*), 48 (*), 49(**), 50 (**), 51 (**), 52 (**). 2) Body 
weights of ethanol-treated Aldh1b1tm2a males were significantly lower than body weights of 
water-treated Aldh1b1tm2a males in weeks: 27(*), 30(*), 31 (*), 32 (*), 33(*), 34 (*), 35 (*), 39 
(*), 40 (**), 41(***), 42 (**), 43 (**), 44(**), 45 (*), 46 (**), 47 (*), 48 (*), 49(**), 50 (*), 51 (*), 
52 (*). Significant ethanol effects are denoted as * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.  
 
Figure S3. 
Representative images of Cyp2e1 immunostaining of the small intestine (A, B), large 
intestine (C, D) and liver (E, F) of wildtype mice treated with water (A, C, E) or ethanol (B, 
D, F). Scale bar for A, B, E, F: 100µm. Scale bar for C, D: 50µm. 
 
Figure S4. 
Representative H&E images of mitotic figures (arrows) in the upper part of large intestinal 
crypts (A) and small intestinal crypts (B); and (C) crypt branching or budding which was 
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observed in the large intestine of 4/14 wildtype and 2/15 Aldh1b1tm2a mice treated with 
ethanol for one year (scale bar: 50µm).  
 
Figure S5. 
(A, B) Bar charts of lymphoma incidence in female (A) and male (B) mice. (C) Number of 
intestinal epithelial tumours per mouse after one year of water- or ethanol treatment of 
wildtype and Aldh1b1tm2a mice. Data are shown as dot plots with mean, n=14-15. No 
significant differences were found between ethanol-treated wildtype and Aldh1b1tm2a mice 
when analysing with Mann-Whitney test. (D) Diameter of intestinal tumours (mm) in ethanol-
treated wildtype and Aldh1b1tm2a mice. Data are shown as mean and SD error bars, n=7-8 
(data on tumour size were not available for one ethanol-treated wildtype mouse with one 
intestinal tumour and one ethanol-treated Aldh1b1tm2a mouse with 3 intestinal tumours). No 
significant differences were found between ethanol-treated wildtype and Aldh1b1tm2a mice 
when analysing with unpaired, two-tailed Student’s t-test. (E, F) Representative H&E images 
of an ethanol-treated Aldh1b1tm2a mouse intestinal tumour showing early invasion. (E) Image 
(scale bar 500µm) with area shown in magnification indicated by a box. (F) Magnification of 
the area highlighted in E (scale bar 50µm), with an arrow indicating early invasion through 
the muscularis mucosae (asterisks). 
 
Figure S6. 
Nuclear p53 immunostaining of intestinal tumours of ethanol-treated wildtype and 
Aldh1b1tm2a mice. Tumours (n=17) were categorised by comparing p53 immunostaining in 
relation to adjacent normal intestinal epithelium as either normal level p53, widespread faint 
up-regulation of p53 in relation to normal tissue or widespread strong up-regulation of p53 
in relation to normal tissue. 
